NDC 69097-158

MELOXICAM

Meloxicam

MELOXICAM is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Meloxicam.

Product ID69097-158_0b0ded9b-1266-417c-867f-41800c993b92
NDC69097-158
Product TypeHuman Prescription Drug
Proprietary NameMELOXICAM
Generic NameMeloxicam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2006-07-19
Marketing CategoryANDA / ANDA
Application NumberANDA077929
Labeler NameCipla USA Inc.
Substance NameMELOXICAM
Active Ingredient Strength8 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 69097-158-07

100 TABLET in 1 BOTTLE (69097-158-07)
Marketing Start Date2006-07-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-158-12 [69097015812]

MELOXICAM TABLET
Marketing CategoryANDA
Application NumberANDA077929
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-07-19

NDC 69097-158-07 [69097015807]

MELOXICAM TABLET
Marketing CategoryANDA
Application NumberANDA077929
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-07-19

NDC 69097-158-15 [69097015815]

MELOXICAM TABLET
Marketing CategoryANDA
Application NumberANDA077929
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-07-19

Drug Details

Active Ingredients

IngredientStrength
MELOXICAM7.5 mg/1

OpenFDA Data

SPL SET ID:bb83cd61-0a82-4fe0-b72e-5b715cbd656d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 152695
  • 311486
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • UPC Code
  • 0369097159078
  • 0369097158071
  • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    Medicade Reported Pricing

    69097015815 MELOXICAM 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    69097015812 MELOXICAM 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    69097015807 MELOXICAM 7.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "MELOXICAM" or generic name "Meloxicam"

    NDCBrand NameGeneric Name
    0179-0179meloxicammeloxicam
    0179-0180meloxicammeloxicam
    0440-5841MeloxicamMeloxicam
    0440-6841MeloxicamMeloxicam
    0615-6568MeloxicamMeloxicam
    0615-6569MeloxicamMeloxicam
    0615-7885MeloxicamMeloxicam
    0615-7886meloxicammeloxicam
    0615-8040MELOXICAMmeloxicam
    0615-8124MELOXICAMMeloxicam
    10544-052MeloxicamMeloxicam
    10544-090MeloxicamMeloxicam
    10544-251MeloxicamMeloxicam
    10544-252MeloxicamMeloxicam
    10544-555meloxicammeloxicam
    10544-631meloxicammeloxicam
    10544-925meloxicammeloxicam
    16571-776MeloxicamMeloxicam
    16571-777MeloxicamMeloxicam
    21695-076MeloxicamMeloxicam
    21695-077Meloxicammeloxicam
    29300-124meloxicammeloxicam
    29300-125meloxicammeloxicam
    33261-070meloxicammeloxicam
    33261-071meloxicammeloxicam
    35356-808meloxicammeloxicam
    68071-1919MELOXICAMMELOXICAM
    68071-2184MELOXICAMMELOXICAM
    68071-1994meloxicammeloxicam
    68071-1993meloxicammeloxicam
    68151-4319meloxicammeloxicam
    68180-501MeloxicamMeloxicam
    68180-502MeloxicamMeloxicam
    68382-051meloxicammeloxicam
    68382-050meloxicammeloxicam
    68462-141MeloxicamMeloxicam
    68462-140MeloxicamMeloxicam
    68788-1701meloxicammeloxicam
    68788-9897meloxicammeloxicam
    68788-9418meloxicammeloxicam
    68788-9898meloxicammeloxicam
    69097-159MELOXICAMMELOXICAM
    69097-158MELOXICAMMELOXICAM
    69336-101MeloxicamMeloxicam
    69336-102MeloxicamMeloxicam
    70518-0031meloxicammeloxicam
    70518-0200MELOXICAMMELOXICAM
    70518-0039meloxicammeloxicam
    70518-0394meloxicammeloxicam
    70518-0171MELOXICAMMELOXICAM

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.